Abstract
Predictable and reproducible production of transgenic rats from a standardized input of egg donors and egg recipients is essential for routine rat model production. In the course of establishing a transgenic rat service, transgenic founders were produced from three transgenes in outbred Sprague-Dawley (SD) rats and four transgenes in inbred Fischer 344 (F344) rats. Key parameters that affect transgenesis efficiency were assessed, including superovulation treatments, methods to prepare pseudopregnant recipients, and microinjection technique. Five superovulation regimens were compared and treatment with 20 IU PMSG and 30 IU HCG was selected for routine use. Four methods to prepare pseudopregnant egg recipients were compared and estrus synchronization with LHRHa and mating to vasectomized males was selected as most effective. More than 80% of eggs survived microinjection when modified pronuclear microinjection needles and DNA buffers were used. The efficiencies of transgenic production in rats and C57BL/6J (B6J) mice were compared to provide a context for assessing the difficulty of transgenic rat production. Compared to B6J mice, SD rat transgenesis required fewer egg donors per founder, fewer pseudopregnant egg recipients per founder, and produced more founders per eggs microinjected. Similar numbers of injection days were required to produce founders. These results suggest that SD rat transgenesis can be more efficient than B6J mouse transgenesis with the appropriate technical refinements. Advances in transgenic rat production have the potential to increase access to rat models.
Similar content being viewed by others
References
Armstrong DT, Opavsky MA (1988) Superovulation of immature rats by continuous infusion of follicle-stimulating hormone. Biol Reprod 39:511–518
Auerbach AB, Norinsky R, Ho W, Losos K, Guo Q, Chatterjee S, Joyner AL (2003) Strain-dependent differences in the efficiency of transgenic mouse production. Transgenic Res 12:59–69
Breban M, Hacquard-Bouder C, Falgarone G (2004) Animal models of HLA-B27-associated diseases. Curr Mol Med 4:31–40
Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD (1985) Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci (USA) 82:4438–4442
Charreau B, Tesson L, Buscail J, Soulillou JP, Anegon I (1996a) Analysis of human CD59 tissue expression directed by the CMV-IE-1 promoter in transgenic rats. Transgenic Res 5:443–50
Charreau B., Tesson L, Soulillou JP, Pourcel C, Anegon I (1996b) Transgenic rats: Technical aspects and models. Transgenic Res 5:223–234
Collidge TA, Lammie GA, Fleming S, Mullins JJ (2004) The role of the renin–angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations. Prog Biophys Mol Biol 84:301–319
Corbin TJ, McCabe JG (2002) Strain variation of immature female rats in response to various superovulatory hormone preparations and routes of administration. Contemp Topics 41:18–23
Cornejo-Cortes MA, Sanchez-Torres C, Vazquez-Chagoyan JS, Suarez-Gomez HM, Garrido-Farina G, Meraz-Rios MA (2006) Rat embryo quality and production efficiency are dependent on gonatdotrophin dose in superovulatory treatments. Lab Animals 40:87–95
Dahl LK, Heine M, Tassinari L (1962) Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194:480–2
Dycaico MJ, Provost GS, Kretz PL, Ransom SL, Moores JC, Short JM (1994) The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat Res 307:461–78
Egwuagu CE, Sztein J, Mahdi RM, Li W, Chao-Chan C, Smith JA, Charukamnoetkanok P, Chepelinsky AB (1999) IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats. J Immunol 162:510–517
Heideman J (1991) Transgenic rats: a discussion. Biotechnology 16:325–333
Henderson KM, Weaver A, Wards RL, Ball K, Lun S, Mullin C, McNatty KP (1990) Oocyte production and ovarian steroid concentrations of immature rats in response to some commercial gonadotrophin preparations. Reprod Fertil Dev 2:671–682
Hirabayashi M, Ito K, Sekimoto A, Hochi S, Ueda M (2001) Production of transgenic rats using young Sprague-Dawley females treated with PMSG and hCG. Exp Anim 50:365–369
Hirabayashi M, Kato M, Ishikawa A, Kaneko R, Yagi T, Hochi S (2005) Factors affecting production of transgenic rats by ICSI-mediated DNA transfer: effects of sonication and freeze-thawing of spermatozoa, rat strains for sperm and oocyte donors, and different constructs of exogenous DNA. Mol Repro Dev 70:422–428
Hochi S, Ninomiya T, Honman M, Yuki A (1991) Successful production of transgenic rats. Anim Biotech 1:175–184
Iannaccone P, Galat V (2002) Production of transgenic rats. In: Pinkert CA (ed) Transgenic animal technology. Academic Press, New York, (pp.235–250)
Ishigame H, Medan MS, Watanabe G, Shi Z, Kish H, Arai KY, Taya K (2004) A new alternative method for superovulation using passive immunization against inhibin in adult rats. Biol Reprod 71:236–243
Kisseberth WC, Brettingen NT, Lohse JK, Sandgren EP (1999) Ubiquitous expression of marker transgenes in mice and rats. Dev Biol 214: 128–138
Kon H, Tohei A, Hokao R, Shinoda M (2005) Estrous cycle stage-independent treatment of PMSG and hCG can induce superovulation in adult Wistar-Imamichi rats. Exp Anim 54:185–187
Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline Transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868–872
Long JA, Evans HM (1922) The Oestrous Cycle in the rat and its associated phenomena. University of California Press, Berkeley
Maurer RA, Erwin CR, Donelson JE (1981) Analysis of 5′ flanking sequences and intron-exon boundaries of the rat prolactin gene. J Biol Chem 256:10524–10528
Michalkiewicz M, Michalkiewicz T (2000) Developing transgenic neuropeptide Y rats. Methods Mol Biol 153:73–89
Mukumoto S, Mori S, Ishikawa H (1995) Efficient induction of superovulation in adult rats by PMSG and HCG. Exp Anim 44:111–118
Pfeifer A (2004) Lentiviral transgenesis. Transgenic Res 13:513–522
Popova E, Krivokharchenko A, Ganten D, Bader M (2002) Comparison between PMSG- and FSH- induced superovulation for the generation of transgenic rats. Mol Reprod Dev 63:177–182
Popova E, Bader M, Krivokharchenko A (2005) Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production. Transgenic Res 14:729–738
Ramos SD, Lee JM, Peuler JD (2001) An inexpensive meter to measure differences in electrical resistance in the rat vagina during the ovarian cycle. J Appl Physiol 91:667–670
Rouleau AMJ, Kovacs PR, Kunz HW, Armstrong DT (1993) Decontamination of rat embryos and transfer to specific pathogen-free recipients for the production of a breeding colony. Lab Animal Sci 43:611–615
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer- directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Sato Y, Igarashi Y, Hakamata Y, Murakami T, Kaneko T, Takahashi M, Seo N, Kobayashi E (2003) Establishment of alb-DsRed2 transgenic rat for liver regeneration research. Biochem Biophys Res Comm 311:478–481
Sotomaru Y, Kamisako T, Hioki K (2005) Estrous stage- and animal age-independent superovulation in the BrlHan: WIST@Jcl(GALAS) rat. Exp Anim 54: 137–141
Spearow JL, Erickson RP, Edwards T, Herbon L (1991) The effect of H-2 region and genetic background on hormone-induced ovulation rate, puberty, and follicular number in mice. Genet Res 57:41–49
Stickrod G (1979) Ketamine/xylazine anesthesia in the pregnant rat. J Am Vet Med Assoc 175:952–953
Swanson ME, Hughes TE, St. Denny I, France DS, Patternitit JR Jr, Tapparelli C, Gfeller P, Bürki K (1992) High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res 1:142–147
Tesson L, Cozzi J, Ménoret S, Rémy S, Usal C, Fraichard A, Anegon I (2005) Transgenic modifications of the rat genome. Transgenic Res 14:531–546
van den Brandt J, Wang D, Kwon S-H, Heinkelein M, Reichardt HM (2004) Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39:94–99
Vaughan DK, Coulibaly SF, Darrow RM, Organisciak DT (2003) A morphometric study of light-induced damage in transgenic rat models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 44:848–855
Vercauteren FG, Clerens S, Roy L, Hamel N, Arckens L, Vandesande F, Alhonen L, Janne J, Szyf M, Cuello AC (2004) Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer’s disease-linked mutations in amyloid precursor protein and presenilin 1. Mol Brain Res 132:241–59
Waller SJ, Ho M-Y, Murphy D (1995) Production of transgenic rodents by microinjection of cloned DNA in fertilized one-cell eggs. In: Glover DM and Hames BD (eds) DNA cloning, vol. 4, Oxford University Press, Oxford, pp 184–229
Walton EA, Armstrong DT (1983) Oocyte normality after superovulation in immature rats. J Reprod Fert 67:309–314
Watson PA, Kim K, Chen KS, Gould MN (2002) Androgen-dependent mammary carcinogenesis in rats transgenic for the Neu proto-oncogene. Cancer Cell 2:67–79
Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC (2005) Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16:2941–2952
Wisløff U, Najjar SM, Ellingsen ø, Haram PM, Swoap S, Al-Share Q, Fernström M, Rezaei K, Lee SJ, Koch LG, Britton SL (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307:418–420
Yang XZ, Han MS, Niwa K, Iannaccone PM (2004) Factors required during preculture of rat oocytes soon after sperm penetration for promoting their further development in a chemically defined medium. J Reprod Dev 50:533–540
Zhou Y, Galat V, Garton R, Taborn G, Niwa K, Iannaccone P (2003) Two-phase chemically defined culture system for preimplantation rat embryos. Genesis 36:129–133
Zucker LM, Zucker TF (1961) Fatty, a new mutation in the rat. J Hered 52:275–278
Acknowledgments
We thank Colin Bishop, Yuji Ikeno, Sean Morrison, R. Scott Turner, Robert Thompson, and Roger Wiggins for providing transgenes and genotyping. We thank Tina Hutchinson and Corey Ziebell for their help managing the rat colonies and Maggie Van Keuren for C57BL/6J microinjection data. We thank Anne Rouleau for advice on mechanical stimulation. T.S. thanks Joe Warren for introducing him to the making of transgenic rats. Support was received from NIH grants CA46592, AR20557, DK34933, and AG013283. Additional support was provided by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000815).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Filipiak, W.E., Saunders, T.L. Advances in transgenic rat production. Transgenic Res 15, 673–686 (2006). https://doi.org/10.1007/s11248-006-9002-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11248-006-9002-x